Shnayder, Natalia A.,
Grechkina, Violetta V.,
Trefilova, Vera V.,
Efremov, Ilya S.,
Dontceva, Evgenia A.,
Narodova, Ekaterina A.,
Petrova, Marina M.,
Soloveva, Irina A.,
Tepnadze, Liia E.,
Reznichenko, Polina A.,
Al-Zamil, Mustafa,
Altynbekova, Gulnara I.,
Strelnik, Anna I.,
Nasyrova, Regina F. (2023) -MetS) is a common ADR that needs an updated multidisciplinary
approach to its prevention and diagnosis
Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) from the standpoint of the pharmacogenomics and pharmacometabolomics. In addition, a new
personalized-agent technology in modeling the interaction between a doctor and a patient to form a
personalized approachGenome-wide association studies (GWAS) have proven to be a powerful
approach to discovering genes
Nasyrova, Regina F.,
Shnayder, Natalia A.,
Osipova, Sofia M.,
Khasanova, Aiperi K.,
Efremov, Ilya S.,
Al-Zamil, Mustafa,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Garganeeva, Natalia P.,
Shipulin, German A. (2023) this risk can be partially modified by the
personalized
selection of APs and their dosing rates, taking
Mukhametzyanov, A.M.,
Asylgareeva, G.M.,
Kaidanek, T.V.,
Rakhmatullina, E.I.,
Enikeev, E. A.,
Sharipova, D. N. (2023) the article considers the possibilities of implementing a practice-oriented
ap-proach in the study